BCL10 (B-cell lymphoma/leukemia 10) is a gene involved in apoptosis signaling and immune response regulation. Mutations in BCL10 have been implicated in the pathogenesis of various lymphomas, particularly mucosa-associated lymphoid tissue (MALT) lymphomas. They have also been reproducibly observed in a smaller proportion of DLBCLs with the frequency in non-MALT lymphomas under some debate.1

Mutation tier

Entity Tier Description
BL 2 relevance in BL not firmly established
DLBCL 1 high-confidence DLBCL gene
FL 2 relevance in FL not firmly established

Mutation incidence

Entity source frequency (%)
BL GAMBL genomes+capture 0.23
BL Thomas cohort 0.40
BL Panea cohort NA
DLBCL GAMBL genomes 3.82
DLBCL Schmitz cohort 7.70
DLBCL Reddy cohort 3.10
DLBCL Chapuy cohort 6.40
FL GAMBL genomes 2.31

Mutation pattern

Entity aSHM Significant selection dN/dS (missense) dN/dS (nonsense)
BL No No 3.224 0.000
DLBCL No Yes 13.754 106.692
FL No Yes 0.000 223.832

## BCL10 Hotspots

Chromosome Coordinate (hg19) ref>alt HGVSp
chr1 85736474 C>T R58Q
chr1 85733390 G>A Q208*
chr1 85733386 A>C L209*

View coding variants in ProteinPaint hg19 or hg38

image

View all variants in GenomePaint hg19 or hg38

image

References

  1. Luminari S, Intini D, Baldini L, Berti E, Bertoni F, Zucca E, Cro L, Maiolo AT, Cavalli F, Neri A. BCL10 gene mutations rarely occur in lymphoid malignancies. Leukemia. 2000 May;14(5):905-8. doi: 10.1038/sj.leu.2401747. PMID: 10803524.